Literature DB >> 7075916

Permeability and morphology of skeletal muscle capillaries in type 1 (insulin-dependent) diabetes mellitus.

H Leinonen, E Matikainen, J Juntunen.   

Abstract

Muscle blood flow and capillary diffusion capacity were determined in 21 Type 1 (insulin-dependent) diabetic patients and in 12 age-matched healthy subjects by measuring the simultaneous clearance of 133xenon and 131iodide from hyperaemic anterior tibial muscle. Blood flow was significantly lower (mean +/- SD: 46.7 +/- 14.1 versus 59.4 +/- 12.9 ml 100 g-1 min-1, p less than 0.02) and capillary diffusion capacity was significantly greater (mean +/- SD: 8.0 +/- 2.1 versus 5.9 +/- 1.3 mol/min, p less than 0.005) in the diabetic patients than in the control subjects. Ultrastructural dimensions and density of capillaries in the gastrocnemius muscle of 11 diabetic patients and six control subjects were also studied. Diabetic and control capillaries did not differ in total capillary area. Compared with normal capillaries, the percentage area of basement membrane and the apparent basement membrane thickness were significantly greater (1.21 +/- 0.6 versus 0.78 +/- 0.2 mu, p less than 0.05) in diabetic capillaries, while there were no significant differences in luminal, endothelial and pericytial areas. There was no difference in capillary density between the two groups. No correlation was found between basement membrane thickness and capillary diffusion capacity in the diabetic patients. We conclude that the greater capillary diffusion capacity is due to increased permeability of diabetic capillaries, and that the basement membrane is probably not rate-limiting in the transcapillary transport of hydrophilic substances in diabetic subjects.

Entities:  

Mesh:

Year:  1982        PMID: 7075916     DOI: 10.1007/bf00283744

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  27 in total

1.  Evaluation of skeletal muscle capillary basement membrane thickness in congestive heart failure.

Authors:  J Longhurst; R J Capone; R Zelis
Journal:  Chest       Date:  1975-02       Impact factor: 9.410

2.  Morphometric analysis of skeletal muscle capillary ultrastructure in inflammatory myopathies.

Authors:  F Jerusalem; M Rakusa; A G Engel; R D MacDonald
Journal:  J Neurol Sci       Date:  1974-11       Impact factor: 3.181

3.  Simultaneous determination of the transcapillary escape rate of albumin and IgG in normal and long-term juvenile diabetic subjects.

Authors:  H H Parving; N Rossing
Journal:  Scand J Clin Lab Invest       Date:  1973-11       Impact factor: 1.713

4.  Muscle capillary basement membrane in juvenile diabetes mellitus.

Authors:  T S Danowski; E R Fisher; R C Khurana; S Nolan; T Stephan
Journal:  Metabolism       Date:  1972-12       Impact factor: 8.694

5.  Theoretical considerations on measurement of capillary diffusion capacity in skeletal muscle by the local clearance method.

Authors:  N A Lassen; J Trap-Jensen
Journal:  Scand J Clin Lab Invest       Date:  1968       Impact factor: 1.713

6.  Skeletal muscle capillaries in diabetics. A quantitative analysis.

Authors:  R Vracko
Journal:  Circulation       Date:  1970-02       Impact factor: 29.690

7.  Comparison of the microangiopathy of systemic lupus erythematosus, dermatomyositis, scleroderma, and diabetes mellitus.

Authors:  W L Norton
Journal:  Lab Invest       Date:  1970-04       Impact factor: 5.662

8.  Hyperglycaemia and diabetic microangiopathy.

Authors:  M D Siperstein; K R Feingold; P H Bennet
Journal:  Diabetologia       Date:  1978-11       Impact factor: 10.122

9.  Capillary circulation and morphology in Duchenne muscular dystrophy.

Authors:  H Leinonen; J Juntunen; H Somer; J Rapola
Journal:  Eur Neurol       Date:  1979       Impact factor: 1.710

10.  Skeletal muscle capillaries in intermittent claudication.

Authors:  J Mäkitie
Journal:  Arch Pathol Lab Med       Date:  1977-09       Impact factor: 5.534

View more
  15 in total

Review 1.  Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs.

Authors:  Miroslav Dostalek; Fatemeh Akhlaghi; Martina Puzanovova
Journal:  Clin Pharmacokinet       Date:  2012-08-01       Impact factor: 6.447

2.  Prevalence of hypertension in type 1 (insulin-dependent) diabetes mellitus.

Authors:  G C Viberti; R Trevisan; R Nosadini
Journal:  Diabetologia       Date:  1991-01       Impact factor: 10.122

Review 3.  Endothelial cell function in diabetic microangiopathy.

Authors:  M Porta; M La Selva; P Molinatti; G M Molinatti
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

Review 4.  Microvascular investigations in diabetes mellitus.

Authors:  S J Chittenden; S K Shami
Journal:  Postgrad Med J       Date:  1993-06       Impact factor: 2.401

Review 5.  The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans.

Authors:  P R Gwilt; R R Nahhas; W G Tracewell
Journal:  Clin Pharmacokinet       Date:  1991-06       Impact factor: 6.447

Review 6.  The role of endothelium in the pathogenesis of diabetic microangiopathy.

Authors:  M La Selva; E Beltramo; P Passera; M Porta; G M Molinatti
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

7.  Transcapillary colloid osmotic gradient, plasma volume and interstitial fluid volume in long-term type 1 (insulin-dependent) diabetes.

Authors:  P Fauchald; J Norseth; J Jervell
Journal:  Diabetologia       Date:  1985-05       Impact factor: 10.122

Review 8.  Albuminuria reflects widespread vascular damage. The Steno hypothesis.

Authors:  T Deckert; B Feldt-Rasmussen; K Borch-Johnsen; T Jensen; A Kofoed-Enevoldsen
Journal:  Diabetologia       Date:  1989-04       Impact factor: 10.122

9.  Increased microvascular fluid permeability in young type 1 (insulin-dependent) diabetic patients.

Authors:  A J Jaap; A C Shore; I B Gartside; J Gamble; J E Tooke
Journal:  Diabetologia       Date:  1993-07       Impact factor: 10.122

10.  Impaired microvascular hyperaemic response to minor skin trauma in type I diabetes.

Authors:  G Rayman; S A Williams; P D Spencer; L H Smaje; P H Wise; J E Tooke
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.